445 related articles for article (PubMed ID: 27756885)
1. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
3. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
4. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
[TBL] [Abstract][Full Text] [Related]
5. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
[TBL] [Abstract][Full Text] [Related]
6. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
Wang M; Cai J; Huang F; Zhu M; Zhang Q; Yang T; Zhang X; Qian H; Xu W
Int J Mol Med; 2015 Feb; 35(2):367-75. PubMed ID: 25483835
[TBL] [Abstract][Full Text] [Related]
8. Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways.
Gao S; Mao F; Zhang B; Zhang L; Zhang X; Wang M; Yan Y; Yang T; Zhang J; Zhu W; Qian H; Xu W
Exp Biol Med (Maywood); 2014 Mar; 239(3):366-75. PubMed ID: 24500984
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.
Rattigan Y; Hsu JM; Mishra PJ; Glod J; Banerjee D
Exp Cell Res; 2010 Dec; 316(20):3417-24. PubMed ID: 20633553
[TBL] [Abstract][Full Text] [Related]
12. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
13. Exposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis.
Zhou N; Zhang Y; Zhang X; Lei Z; Hu R; Li H; Mao Y; Wang X; Irwin DM; Niu G; Tan H
Int J Mol Sci; 2015 May; 16(6):11966-82. PubMed ID: 26016502
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
Front Immunol; 2018; 9():871. PubMed ID: 29867925
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
[TBL] [Abstract][Full Text] [Related]
16. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype.
Ulivi V; Tasso R; Cancedda R; Descalzi F
Stem Cells Dev; 2014 Aug; 23(16):1858-69. PubMed ID: 24720766
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
